Palantir Technologies Inc
That support resulted in the company's UK office being blocked on Thursday by activists from Healthcare Workers for Palestine.
What Happened: Activists outside of Palantir's UK offices expressed distrust with Palantir's having patient data.
"This new deal [with Palantir] doesn't just affect me as a doctor," Harriet, a protest organizer who works as a junior doctor in the National Health Service (NHS), told Middle East Eye.
"They have been involved in racial profiling of marginalized communities in America and supporting the Israeli occupation. If they have our patient data, I do not trust that they will use it ethically," she added.
After having a good stride for most of the year, Palantir's stock has paused over the past month. It is down over 15% over the past month.
The stock is 24% below its 52-week high of $21.85. While temporary headwinds such as the repercussions of the Israel-Hamas war, potential disagreements over data ownership with the U.S. Army, etc., continue to pull down the stock, fundamentals remain solid.
For those who continue to believe in the fundamental strength of Palantir's business, the current slide may be a buy-the-dip opportunity.
Cathie Wood's Ark Invest has been doubling down on Palantir stock amid correction, buying over $27 million worth of stock recently.
